openPR Logo
Press release

Infantile And Juvenile Onset Hypophosphatasia Treatment Market Is Estimated To Witness Expansion At Single-Digit CAGR Throughout the Forecast Period

Infantile And Juvenile Onset Hypophosphatasia Treatment

The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short stature and weak bones with loss of mobility, and may also result in premature death. According to U.S. Food and Drug Administration, it is estimated that in about 100,000 newborns, one suffers severe hypophosphatasia. The mildest form of hypophosphatasia is called odontohypophosphatasia and is affects teeth. Infantile and perinatal hypophosphatasia is an autosomal recessive disease. Hypophosphatasia is an ultra-rare disease affecting < 20 people per million and it effects people of all ages as it is caused due to deficiency of an enzyme known as tissue non-specific alkaline phosphatase (TNSALP), which leads to high level of tissue non-specific alkaline phosphatase (TNSALP) substrates, including inorganic pyrophosphate. The adult form of this disease and odontohypophosphatasia is an autosomal recessive or autosomal dominant disease.

Treatment and management of hypophosphatasia (HPP) is symptomatic and supportive, it aims at addressing symptoms of disease such as thiazide diuretics for hypercalcemia, ventilator support, occupational therapy and surgery for bone fractures. In October 2015, the enzyme replacement therapy has been recently approved for the treatment of abnormal bone structure in people with onset hypophosphatasia (HPP). The HPP community are helping to bring programs that will bring new and treatment options to people with rare diseases. Currently, clinical trials are conducted, wherein a large number of organization are actively participating in several research programs to develop novel therapies for infantile and juvenile-onset hypophosphatasia treatment. Introduction of several novel therapy, breakthrough therapy designation, orphan drug designation for rare diseases, financial incentives and grants by the government, clinical studies on safety and efficacy of products, is expected to be the biggest hit in the global infantile and juvenile-onset hypophosphatasia treatment over the forecast period. Gaps in making hypophosphatasia (HPP) health priority, patients’ non-adherence to therapy regime, high therapy cost, less number of approved therapies, failure in clinical trial at the late phase are some of the factors restraining the infantile and juvenile-onset hypophosphatasia treatment market.

Request to Sample Report @ https://www.persistencemarketresearch.com/samples/22495

The global Infantile and Juvenile-onset Hypophosphatasia Treatment market is segmented on basis of treatment type, end user and geography

Segment by Treatment Type

Supportive Care
Enzyme Replacement Therapy

Segment by End User

Hospitals
Specialty Clinics
Clinical Research Organizations
Others

Global Infantile and Juvenile-onset Hypophosphatasia Treatment market is segmented by treatment type, and end user. Based on the treatment type, global Infantile and Juvenile-onset Hypophosphatasia treatment market is segmented as supportive care and enzyme replacement therapy. On the basis of end user, the global infantile and juvenile-onset hypophosphatasia treatment market is segmented into hospital, clinics, clinical research organizations and others. Rise in patient population of hypophosphatasia, increased awareness and new product/therapy launch is said to drive the global Infantile and Juvenile-onset hypophosphatasia treatment market during the forecast period. Whereas inadequate access to health care, cost and availability of essential medicines and lack of standardized tools for diagnosis and treatment will hamper the growth of global infantile and juvenile-onset hypophosphatasia treatment market.

By Geography, the global Infantile and juvenile-onset hypophosphatasia treatment market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is estimated to lead the global Infantile and Juvenile-onset Hypophosphatasia Treatment market due to rise in cases of hypophosphatasia in United States, Europe market is also projected to experience high growth in the near future. Asia Pacific market is anticipated to grow at the fastest growth rate during the forecast period, owing to factors such as rising standard of living, lifestyle changes, rise in research and development, government initiatives, drug designations such as breakthrough therapy, Orphan drug designation by FDA helps company to work collaboratively with sponsors to expedite the drug development process.

Request Report TOC @ https://www.persistencemarketresearch.com/toc/22495

Some of the major players in global Infantile and Juvenile-onset Hypophosphatasia Treatment market are Alexion Pharmaceuticals Inc., Novartis A.G, and Others.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infantile And Juvenile Onset Hypophosphatasia Treatment Market Is Estimated To Witness Expansion At Single-Digit CAGR Throughout the Forecast Period here

News-ID: 1599395 • Views:

More Releases from Persistence Market Research

Food Holding Equipment Market Expected to Reach a Valuation of US$ 7.5 Bn by 2031
Food Holding Equipment Market Expected to Reach a Valuation of US$ 7.5 Bn by 203 …
Introduction The Food Holding Equipment market plays a vital role in the foodservice and hospitality industries, ensuring that prepared foods are stored at the appropriate temperatures until they are served. With growing demand in the foodservice sector and heightened expectations for food safety, food holding equipment has become indispensable in maintaining food quality and compliance with health standards. This report provides a comprehensive analysis of the Food Holding Equipment market, covering
Non-Dairy Ice Cream Market Expected to Reach a Valuation of US$ 3.4 Bn by 2031
Non-Dairy Ice Cream Market Expected to Reach a Valuation of US$ 3.4 Bn by 2031
Introduction The Non-Dairy Ice Cream market is witnessing significant growth as consumers increasingly seek plant-based alternatives to traditional dairy products. Health-conscious individuals, lactose-intolerant consumers, and those adhering to vegan diets are driving the demand for non-dairy ice creams. This market includes products made from almond, coconut, soy, and other plant-based sources, providing a range of flavors and textures that cater to diverse consumer preferences. This report provides a comprehensive analysis of
Plant-based Yogurt Market Expected to Reach a Valuation of US$ 10.9 Bn by 2030
Plant-based Yogurt Market Expected to Reach a Valuation of US$ 10.9 Bn by 2030
Introduction The Plant-based Yogurt market is experiencing significant growth, driven by increasing consumer demand for dairy alternatives, health consciousness, and environmental sustainability. As consumers become more aware of lactose intolerance, dairy allergies, and the health benefits of plant-based diets, the popularity of plant-based yogurt has surged globally. This report provides an in-depth analysis of the plant-based yogurt market, examining trends, key growth drivers, challenges, and future projections. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐏𝐃𝐅-
Aquafeed Additives Market Expected to Reach a Valuation of US$ 5.6 Bn by 2030
Aquafeed Additives Market Expected to Reach a Valuation of US$ 5.6 Bn by 2030
Introduction The Aquafeed Additives Market is gaining prominence as aquaculture continues to expand globally, driven by rising demand for seafood and advancements in fish farming techniques. Aquafeed additives play a crucial role in enhancing the nutritional quality, growth performance, and health of aquatic species, ultimately improving aquaculture efficiency and productivity. This report provides an in-depth analysis of the Aquafeed Additives Market, exploring current trends, growth drivers, challenges, and future projections. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞

All 5 Releases


More Releases for Infantile

Infantile Spasms Therapeutics Market Analysis by Key Players & Industry Size 202 …
According to a new report published by Allied Market Research, titled, " Infantile Spasms Therapeutics Market by Formulation Type (Solid and Liquid) and by Route of Administration (Oral and Parenteral) - Global Opportunity Analysis and Industry Forecast, 2021-2028" The Global market size of Immunomodulators is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from
Infantile Spasms Therapeutics Market to Boost Revenue with Massive Growth
Global Infantile Spasms Therapeutics Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Infantile Spasms Therapeutics Market by Formulation Type (Solid and Liquid)
Global Infantile Spasms Therapeutics Market 2018:- Mallinckrodt, H. Lundbeck, In …
Market Research Store Exposed a new deep Industry research report focuses on Infantile Spasms Therapeutics Market, delivers detailed analysis of market and future prospects of Infantile Spasms Therapeutics market. The critical and significant data in the study makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis by the industry professionals. The Infantile Spasms Therapeutics Market report provides the complete analysis of Infantile Spasms
Infantile and Juvenile-onset Hypophosphatasia Treatment Market to Undertake Stra …
The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short
Infantile Spasms Therapeutics Market Scope and Opportunities Analysis 2017 – 2 …
Infantile spasms therapeutics are used for the treatment of seizures or an epilepsy syndrome in young children, usually aged one year or below. Infantile spasm refers to sudden stiffening of the body, the arms, and the legs or forward bending of the head. Primary treatments for infantile spams include steroid therapy and an anti-seizure medicine called Sabril. Infantile spasms are also known as the West syndrome, as the disease was
Global Infantile Spasms Therapeutics Market 2017-2021
Qyresearchreports include new market research report Global Infantile Spasms Therapeutics Market Professional Survey Report 2017 to its huge collection of research reports. In a highly dynamic global market for Infantile Spasms Therapeutics, companies need to constantly evolve to stay ahead of the curve. To do so, they need accurate information on the market. The recent report endeavors to help them achieve their growth targets by offering crucial information on the global